|
| |
Articles
1-108 out of 108 article(s)
| Title |
Author |
Type |
Date |
Words |
| Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices. |
|
|
May 3, 2012 |
831 |
| Ethical Corporation: Pfizer, Hormel Foods and Bill Wohl (former Chief Communications Officer for HP and SAP) join global industry gathering to discuss crisis communications in the age of social media. |
|
Industry overview |
Feb 14, 2012 |
456 |
| IRBNet Announces 4th Annual IRBNet Ethics in Human Research Protection Award. |
|
|
Dec 19, 2011 |
1005 |
| Enhancing credibility of chemical safety studies: no consensus. |
Tweedale, Lony |
|
Dec 1, 2011 |
789 |
| Health policy and ethics; a critical examination of values from a global perspective. |
|
Book review |
Dec 1, 2011 |
184 |
| SCCE's 10th Annual Compliance & Ethics Institute, With Over 800 Attendees-590 In-House Compliance and Ethics Practitioners-Breaks Previous Record. |
|
|
Sep 21, 2011 |
726 |
| Flacking for Big Pharma: drugmakers don't just compromise doctors; they also undermine the top medical journals and skew the findings of medical research. |
Washington, Harriet A. |
|
Jun 22, 2011 |
6271 |
| A guide to the perplexed: how to navigate conflicting research ethics policies. |
Kimmelman, Jonathan; McDonald, Michael; Avard, Denise |
|
Jun 22, 2011 |
3929 |
| Pharma ethics code isn't working! |
Verschoor, Curtis C. |
|
Feb 1, 2011 |
1446 |
| Industry-Physician ties persist. |
Anderson, Jane |
Brief article |
Dec 1, 2010 |
182 |
| Johnson & Johnson (New Brunswick NJ) lost a huge jury verdict in Louisiana for making misleading claims about the safety of the company's Risperdal antipsychotic drug. |
|
|
Oct 18, 2010 |
320 |
| Lytix Biopharma AS Announces Approval by Hungarian Authorities and Ethics Committee to Start Phase IIa Clinical Trial with LytixarTM (LTX-109) in Gram Positive Skin Infections. |
|
|
Sep 1, 2010 |
349 |
| Compliance and Ethics Attorney Complements CIS Service Offerings. |
|
|
Jul 8, 2010 |
303 |
| CREW Asks HHS IG to Investigate Tobacco Panel's Conflicts of Interest. |
|
|
Jun 7, 2010 |
504 |
| FDA urges doctors to report misleading drug pitches. |
|
|
May 18, 2010 |
835 |
| Whistleblower Lawyers Comment on New England Journal of Medicine Study. |
|
|
May 12, 2010 |
720 |
| Doctor groups set new policy to curb industry influence. |
|
|
May 5, 2010 |
378 |
| Pfizer gave doctors $35 million in last half of 2009. |
|
|
Apr 6, 2010 |
764 |
| Glaxo Avandia study spurs journal to urge change in reviewers. |
|
|
Apr 6, 2010 |
460 |
| Pharmaceutical ads really are honest. |
|
|
Apr 1, 2010 |
566 |
| Ethisphere Announces Annual List of 100 Most Influential People in Business Ethics. |
|
Directory |
Dec 17, 2009 |
660 |
| France Biotech, in collaboration with Eurobiomed, is to organize its 5th Bioethics Forum on Friday, December 11th, at the Musee du Carre d'Art in Nomes. |
|
|
Oct 22, 2009 |
484 |
| Pharma industry unites to protect supply chain integrity. |
Beil, Tom |
|
Sep 1, 2009 |
1480 |
| Resolving ethical dilemmas; a guide for clinicians, 4th ed. |
|
Book review |
Sep 1, 2009 |
130 |
| In a $5.4 million deal struck with 35 state Attorneys General, the Food and Drug Administration (FDA) has forced a moral conscience on Merck and Schering Plough. |
|
|
Sep 1, 2009 |
110 |
| IOM issues 16 conflict of interest recommendations. |
Schneider, Mary Ellen |
|
Jun 1, 2009 |
800 |
| IOM seeks limits on industry influence on patient care. |
|
|
May 5, 2009 |
312 |
| Partners curbs doctors' drug industry ties. |
|
|
Apr 21, 2009 |
770 |
| Slash drugmaker influence on care, group urges. |
|
|
Apr 7, 2009 |
390 |
| ECI Reveals Innovations in Training: Novartis Employees Play Video Games to Learn about Code of Ethics. |
|
|
Mar 12, 2009 |
367 |
| Feds to crack down on doctors who take kickbacks. |
|
|
Mar 10, 2009 |
1170 |
| Outsourcing of drug trials faulted. |
|
|
Feb 24, 2009 |
703 |
| FDA Advisory Committees: Process for Recruiting Members and Evaluating Potential Conflicts of Interest. |
|
|
Nov 1, 2008 |
665 |
| Career moves. |
Gilbert, Susan |
|
Sep 1, 2008 |
537 |
| Research and Markets: Benchmark Genzymes Performance Against Key Rivals in the Ethical Pharmaceutical Sector Today. |
|
|
Jul 9, 2008 |
189 |
| Research and Markets: Benchmark Serviers Performance Against Key Rivals In The Ethical Pharmaceutical Sector. |
|
|
Jul 9, 2008 |
190 |
| MDs paid millions to dispense drugs. |
Gerson, Charlotte |
|
Jul 1, 2008 |
549 |
| This Analysis Examines the Historical and Forecast Performance for Sepracor in the Ethical Pharmaceutical Sector. |
|
|
Mar 31, 2008 |
163 |
| This Analysis Examines the Historical and Forecast Performance for Mitsubishi Tanabe in the Ethical Pharma Sector. |
|
|
Mar 7, 2008 |
146 |
| Research and Markets: New Report Benchmarks Bayer Schering's Performance against Key Rivals in the Ethical Pharmaceutical Sector. |
|
Report |
Feb 11, 2008 |
220 |
| Merck immunologist admits injecting cancer viruses in vaccines. |
Gerson, Charlotte |
Brief article |
Jan 1, 2008 |
124 |
| Research and Markets: Benchmark Abbotts Performance Against Key Rivals In The Ethical Pharmaceutical Sector. |
|
|
Nov 23, 2007 |
160 |
| Reportlinker.com: Get a Deep Insight into Genentech's Strategy in the Ethical Pharmaceutical Sector. |
|
|
Oct 22, 2007 |
736 |
| Research and Markets: Examine the Historical and Forecast Performance for Bayer Schering in the Ethical Pharma Sector. |
|
|
Oct 1, 2007 |
168 |
| The networked industry and its pitfalls: in the following paper, Adriana Salvatore and Paolo Prisco from BearingPoint, discuss the opportunities and associated risks using a network of external professionals. The potential implications of such risks and the relevant measures that companies should put in place are detailed. |
Salvatore, Adriana; Prisco, Paolo |
|
Sep 1, 2007 |
1349 |
| Limiting access to physicians' prescriber data. |
Lax, Jonathan |
|
Aug 31, 2007 |
749 |
| Ethics issues still dog pharmaceutical industry. |
Verschoor, Curtis C. |
|
May 1, 2007 |
1324 |
| Research and Markets: Gain an Insight into Mckesson Corporation - a Leading Distributor of Ethical and Proprietary Drugs Throughout North America. |
|
|
Mar 30, 2007 |
307 |
| Doing the right thing: the importance of maintaining integrity in the workplace. |
Gaye-Anderson, Keisha |
|
Mar 1, 2007 |
557 |
| Ethics in pharmaceutical marketing. |
|
Brief article |
Feb 1, 2007 |
124 |
| How drug companies use bully tactics to get your business. |
|
|
Feb 1, 2007 |
1086 |
| Do we really need the gifts? |
Levin, Alex V. |
|
Feb 1, 2007 |
932 |
| Questions on the independence and reliability of Cochrane reviews, with a focus on measles-mumps-rubella vaccine. |
Miller, Clifford G. |
|
Dec 22, 2006 |
5308 |
| Research and Markets: Examine the Financial Performance of the Ethical Pharmaceutical - Eisai. |
|
|
Dec 15, 2006 |
189 |
| Research and Markets: Learn How Roche Is Forecast To Achieve The Strongest Ethical Sales Growth Rate Among The Big Pharma Peer Set Over 2005-11. |
|
|
Nov 16, 2006 |
163 |
| Research and Markets: Benchmark Boehringer Ingelheim's Performance against Key Rivals in the Ethical Pharmaceutical Sector in This 2006 Pharmavitae Profile. |
|
|
Nov 13, 2006 |
194 |
| Corruption costs health services billions of dollars globally. |
|
Brief article |
Nov 1, 2006 |
107 |
| Research and Markets: Examine AstraZeneca's Performance Against Key Rivals in the Ethical Pharmaceutical Sector. |
|
|
Oct 25, 2006 |
161 |
| Analyze Historical and Forecast Ethical Sales Performance of Pharmaceutical Group Altana. |
|
|
Oct 19, 2006 |
195 |
| Ethics & Compliance Officer Association, University of Chicago to Co-Sponsor Event on the Financial Impact of Ethics and Compliance Programs. |
|
|
Sep 6, 2006 |
259 |
| Drug experiments go horribly wrong. |
Gerson, Charlotte |
|
May 1, 2006 |
626 |
| Pharma industry has many ethics issues. |
Verschoor, Curtis C. |
|
Feb 1, 2006 |
1369 |
| Research and Markets: An analysis of McKesson Corporation, one of the leading providers of ethical and proprietary drugs in North America. |
|
Company Profile |
Jan 26, 2006 |
413 |
| Ethical conflicts may affect FDA ruling on SSRI warning. |
Frieden, Joyce |
|
Jan 15, 2006 |
533 |
| SANKYO PHARMA Focuses on Ethical Medicine Throughout Europe. |
|
|
Dec 12, 2005 |
336 |
| Benchmark Almiralls Performance against Key Players in the Ethical Pharmaceuticals Market. |
|
|
Nov 24, 2005 |
126 |
| Benchmark Sanofi-Aventiss Performance against Key Rivals in the Ethical Pharmaceutical Sector. |
|
|
Nov 23, 2005 |
122 |
| Benchmark Kings Performance Against Key Rivals in the Ethical Pharmaceutical Sector. |
|
|
Nov 23, 2005 |
126 |
| In-Depth Analysis of the Ethical Pharmaceutical Deals That the Top 20 Pharmaceutical Companies Made between January 2000 and May 2005. |
|
|
Nov 21, 2005 |
377 |
| Manipulating medical study data: studies on new drugs and medical devices are being manipulated by their manufacturers through the use of flawed studies, in-pocket experts, and pressure on the FDA. |
Williamsen, Kurt |
Cover Story |
Sep 5, 2005 |
1933 |
| Should experts with potential conflicts of interest be allowed to serve on FDA advisory panels? |
Antony, Paul; Furberg, Curt D. |
|
Sep 1, 2005 |
735 |
| Should experts with potential conflicts of interest be allowed to serve on FDA advisory panels? |
Antony, Paul; Furberg, Curt D. |
|
Aug 15, 2005 |
726 |
| Should experts with potential conflicts of interest be allowed to serve on FDA advisory panels? |
Antony, Paul; Furberg, Curt D. |
|
Aug 15, 2005 |
729 |
| Patients, patents, profits. |
Maschke, Karen |
|
Jul 1, 2005 |
492 |
| Authenticity and ambivalence: toward understanding the enhancement debate. |
Parens, Erik |
|
May 1, 2005 |
6895 |
| Cameroon government suspends trial of AIDS drug amid ethical concerns. |
|
|
May 1, 2005 |
255 |
| Two popular drugs have recently been the subject of some scrutiny. |
|
|
Mar 22, 2005 |
96 |
| How Big Pharma blew it: bad choices and PR gaffes have finally caught up with the drug industry. |
Hawthorne, Fran |
|
Dec 1, 2004 |
2313 |
| Carb stupid. |
|
Brief Article |
Sep 1, 2004 |
277 |
| Leptoprin lies. |
|
Brief Article |
Sep 1, 2004 |
198 |
| A spoon full of sugar: what drug companies don't want you to know. |
Eichenseher, Tasha |
|
Mar 1, 2004 |
991 |
| Demonizing drugmakers: the political assault on the pharmaceutical industry. |
Bandow, Doug |
|
Sep 1, 2003 |
6566 |
| Nancy Olivieri's six-year struggle with a Canadian drug company illustrates how truth, justice and the Western way is the rhetoric of Superman comics. (Seriously). |
|
Brief Article |
Jul 1, 2003 |
219 |
| Drug safety 101. |
|
|
Mar 22, 2003 |
1437 |
| Makes blood pressure rise. (Names in the News). |
Mokhiber, Russell |
Brief Article |
Mar 1, 2003 |
213 |
| 23. Horses face lives of unnecessary abuse. (People). |
|
|
Feb 1, 2003 |
394 |
| Pfizer fraud. (Names in the News). |
Mokhiber, Russell |
Brief Article |
Oct 1, 2002 |
218 |
| Access to medicines and the rhetoric of responsibility. |
Barry, Christian; Raworth, Kate |
|
Oct 1, 2002 |
7966 |
| Junk-mail Prozac? (Policy & Practice). |
Perlstein, Steve |
Brief Article |
Aug 1, 2002 |
115 |
| The great hormone hoax. (The Front). |
Alliua, Amy; Pearson, Cynthia |
|
Jul 1, 2002 |
1188 |
| Medication, testing and psychotherapy-be critical! |
Baer, Michael A. |
|
Jul 1, 2002 |
809 |
| Pope criticizes `hedonistic' medicines. (World). |
Donovan, Gill |
Brief Article |
Apr 26, 2002 |
242 |
| Corporate critic activist calls for ethical sanctions. (Ethics). |
Verschoor, Curtis C. |
Brief Article |
Mar 1, 2002 |
749 |
| Why Do Unfortunate Things Happen to Good Corporate Citizens? |
Versohoor, Curtis C. |
|
Nov 1, 2001 |
1170 |
| September 11: What Happens Now? |
James, John S. |
Brief Article |
Sep 21, 2001 |
1038 |
| Drug use on the rise. (News you can use). |
Fuchs, Nan Kathryn |
Brief Article |
Sep 1, 2001 |
281 |
| Alleged Unethical Behaviors and Schering-Plough. |
Verschoor, Curtis C. |
Brief Article |
Jul 1, 2001 |
866 |
| RESPONSE TO SEXOLOGY AND THE PHARMACEUTICAL INDUSTRY: THE THREAT OF CO-OPTATION. |
Tiefer, Leonore |
|
May 1, 2001 |
1531 |
| S Africa versus Big Pharma. |
|
Brief Article |
Apr 1, 2001 |
875 |
| AIDS Culprits. |
|
|
Mar 1, 2001 |
2022 |
| The heavy cost of Malaria and AIDS. |
De GIORGIO, EMMANUELLE MOORS |
|
Jul 1, 2000 |
1712 |
| Why curing baldness is more lucrative than saving African lives. |
VESELY, MILAN |
Brief Article |
Jul 1, 2000 |
775 |
| Costs of Corporate Science. |
Cray, Charlie |
Brief Article |
Jun 1, 2000 |
313 |
| Placebos for depression attract scrutiny. |
Bower, B. |
Brief Article |
Apr 29, 2000 |
623 |
| People making a difference (Geoff and Dara Lockyer). |
Nguyen, Goretti |
|
Feb 1, 1998 |
481 |
| Drug company promotions may influence doctors, study says. |
Shoop, Julie Gannon |
Brief Article |
May 1, 1994 |
342 |
| ROYCE LABORATORIES ANNOUNCES RECEIPT OF FDA LETTER |
|
|
Jul 8, 1992 |
476 |
| Drug fiends: even inside Johnson & Johnson, public safety can take a back seat to profits. |
Mintz, Morton |
|
Dec 1, 1991 |
6530 |
|
